10,987 SPDR S&P Biotech ETF $XBI Shares Purchased by Sigma Planning Corp

Sigma Planning Corp raised its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 525.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 13,077 shares of the exchange traded fund’s stock after buying an additional 10,987 shares during the quarter. Sigma Planning Corp’s holdings in SPDR S&P Biotech ETF were worth $2,062,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Compass Ion Advisors LLC grew its holdings in shares of SPDR S&P Biotech ETF by 3.0% during the 3rd quarter. Compass Ion Advisors LLC now owns 3,993 shares of the exchange traded fund’s stock valued at $630,000 after acquiring an additional 117 shares in the last quarter. Citizens Financial Group Inc. RI increased its stake in shares of SPDR S&P Biotech ETF by 3.7% in the third quarter. Citizens Financial Group Inc. RI now owns 7,648 shares of the exchange traded fund’s stock worth $1,206,000 after acquiring an additional 276 shares during the last quarter. Simplicity Wealth LLC increased its stake in shares of SPDR S&P Biotech ETF by 5.3% in the third quarter. Simplicity Wealth LLC now owns 2,513 shares of the exchange traded fund’s stock worth $396,000 after acquiring an additional 127 shares during the last quarter. Sowell Financial Services LLC raised its holdings in shares of SPDR S&P Biotech ETF by 1.7% during the third quarter. Sowell Financial Services LLC now owns 8,058 shares of the exchange traded fund’s stock worth $1,271,000 after acquiring an additional 134 shares in the last quarter. Finally, Canton Hathaway LLC raised its holdings in shares of SPDR S&P Biotech ETF by 12.5% during the third quarter. Canton Hathaway LLC now owns 7,475 shares of the exchange traded fund’s stock worth $1,179,000 after acquiring an additional 830 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 2.9%

Shares of NYSEARCA:XBI opened at $154.84 on Wednesday. The firm has a market cap of $10.80 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 1 year low of $106.30 and a 1 year high of $169.89. The business has a fifty day simple moving average of $157.04 and a 200 day simple moving average of $141.08.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.